Literature DB >> 17238983

Breast cancer-related lymphedema--what are the significant predictors and how they affect the severity of lymphedema?

Atilla Soran1, Gina D'Angelo, Mirsada Begovic, Figen Ardic, Ali Harlak, H Samuel Wieand, Victor G Vogel, Ronald R Johnson.   

Abstract

According to the American Cancer Society, there are currently 2 million breast cancer (BC) survivors in the USA and 20% of them cope with lymphedema (LE). The primary aim of this study was to determine the predictive factors of BC-related LE. The secondary aim was to investigate the impact of predictors on the severity of LE. The study design was intended to be a 1:2 matched case-control study. Instead, we stratified on age (+/-10 years), radiation therapy (y/n), and type of operation (SM/MRM/MRM with tram). Patients who underwent BC surgery between 1990 and 2000 at UPMC Magee-Womens Hospital were reviewed for LE. Data were collected on 52 women with LE and 104 female controls. Logistic regression was utilized to assess the relationship between risk factors and LE. Ordinal logistic regression was performed to determine the association between risk factors and severity of LE. Severity was defined according to the volume difference between affected and unaffected limbs. Risk factors considered were occupation/hobby (hand use), TNM stage, number of dissected nodes, number of positive nodes, tumor size, infection, allergy, diabetes mellitus, hypertension, hypothyroidism, chronic obstructive pulmonary disease, and body mass index (BMI). LE was mild in 43 patients and was moderate/severe in nine patients. The level of hand use in the control group was categorized as low in 56 (54%), medium in 15 (14%), and high in 33 (32%) patients. The corresponding frequencies were 14 (33%), 6 (14%) and 23 (53%) for patients with mild LE and 3 (33%), 1 (11%), 5 (56%) for patients with moderate/severe LE (p < 0.05). Infection of the operated side arm was reported by two (2%) patients in the control group, 14 (33%) patients with mild LE and five (56%) patients with moderate/severe LE (p < 0.05). The mean BMI was 26.1 kg/m(2) (SD 4.9) for the control group, 29.0 kg/m(2) (SD 5.9) for the mild LE group and 30.9 kg/m(2) (SD 7.5) for patients with moderate/severe LE (p < 0.05). The results of this stratified case-control study demonstrated that the risk and severity of LE was statistically related to infection, BMI, and level of hand use.

Entities:  

Mesh:

Year:  2006        PMID: 17238983     DOI: 10.1111/j.1524-4741.2006.00342.x

Source DB:  PubMed          Journal:  Breast J        ISSN: 1075-122X            Impact factor:   2.431


  48 in total

1.  Risk factors for lymphedema in a prospective breast cancer survivorship study: the Pathways Study.

Authors:  Marilyn L Kwan; Jeanne Darbinian; Kathryn H Schmitz; Rebecca Citron; Paula Partee; Susan E Kutner; Lawrence H Kushi
Journal:  Arch Surg       Date:  2010-11

2.  Impact of body mass index and weight fluctuation on lymphedema risk in patients treated for breast cancer.

Authors:  Lauren S Jammallo; Cynthia L Miller; Marybeth Singer; Nora K Horick; Melissa N Skolny; Michelle C Specht; Jean O'Toole; Alphonse G Taghian
Journal:  Breast Cancer Res Treat       Date:  2013-11       Impact factor: 4.872

3.  Enhancing Supportive-Educative Nursing Systems to Reduce Risk of Post-Breast Cancer Lymphedema.

Authors:  Jane M Armer; Robin P Shook; Melanie K Schneider; Constance W Brooks; Julie Peterson; Bob R Stewart
Journal:  Self Care Depend Care Nurs       Date:  2009-10

Review 4.  Management of secondary lymphedema related to breast cancer.

Authors:  Oren Cheifetz; Louise Haley
Journal:  Can Fam Physician       Date:  2010-12       Impact factor: 3.275

Review 5.  A systematic review of the effect of low-level laser therapy in the management of breast cancer-related lymphedema.

Authors:  Mohammed Taher Ahmed Omar; Afaf Ahmed Mohamed Shaheen; Hamayun Zafar
Journal:  Support Care Cancer       Date:  2012-08-09       Impact factor: 3.603

6.  The short-term effects of low-level laser therapy in the management of breast-cancer-related lymphedema.

Authors:  Abuzer Dirican; Oya Andacoglu; Ronald Johnson; Kandace McGuire; Lisa Mager; Atilla Soran
Journal:  Support Care Cancer       Date:  2010-05-06       Impact factor: 3.603

7.  Treatment-related risk factors for arm lymphedema among long-term breast cancer survivors.

Authors:  Nandita Das; Richard N Baumgartner; Elizabeth C Riley; Christina M Pinkston; Dongyan Yang; Kathy B Baumgartner
Journal:  J Cancer Surviv       Date:  2015-04-26       Impact factor: 4.442

8.  The role of occupational upper extremity use in breast cancer related upper extremity lymphedema.

Authors:  Gulgun Tahan; Ronald Johnson; Lisa Mager; Atilla Soran
Journal:  J Cancer Surviv       Date:  2009-12-06       Impact factor: 4.442

9.  Older breast cancer survivors: factors associated with self-reported symptoms of persistent lymphedema over 7 years of follow-up.

Authors:  Kerri M Clough-Gorr; Patricia A Ganz; Rebecca A Silliman
Journal:  Breast J       Date:  2009-11-24       Impact factor: 2.431

10.  Lymphangiosarcoma of the arm presenting with lymphedema in a woman 16 years after mastectomy: a case report.

Authors:  Yasir J Sepah; Masood Umer; Asim Qureshi; Shaista Khan
Journal:  Cases J       Date:  2009-09-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.